Ieq Capital LLC purchased a new stake in CME Group Inc. (NASDAQ:CME - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 15,371 shares of the financial services provider's stock, valued at approximately $3,394,000.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CME. Whipplewood Advisors LLC lifted its holdings in shares of CME Group by 2,075.0% during the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider's stock worth $26,000 after purchasing an additional 83 shares during the period. Elkhorn Partners Limited Partnership purchased a new position in CME Group during the 4th quarter worth $27,000. Hilton Head Capital Partners LLC acquired a new stake in shares of CME Group in the 4th quarter worth $28,000. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in shares of CME Group in the 2nd quarter worth $28,000. Finally, Legacy Wealth Managment LLC ID boosted its holdings in shares of CME Group by 191.9% in the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider's stock valued at $29,000 after acquiring an additional 71 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.
CME Group Price Performance
Shares of NASDAQ:CME opened at $279.17 on Tuesday. The firm has a market capitalization of $100.38 billion, a price-to-earnings ratio of 23.68, a price-to-earnings-growth ratio of 3.27 and a beta of 0.23. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The business's 50 day simple moving average is $251.43 and its 200-day simple moving average is $279.47. CME Group Inc. has a 12 month low of $218.31 and a 12 month high of $329.16.
CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.08. The firm had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.CME Group's quarterly revenue was up .8% on a year-over-year basis. During the same period last year, the business posted $2.96 EPS. As a group, equities analysts forecast that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group's dividend payout ratio (DPR) is 44.11%.
Insider Transactions at CME Group
In other CME Group news, Director William R. Shepard acquired 325 shares of the company's stock in a transaction dated Thursday, June 25th. The stock was acquired at an average cost of $230.57 per share, with a total value of $74,935.25. Following the purchase, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.30% of the company's stock.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on CME shares. Rothschild & Co Redburn raised shares of CME Group from a "neutral" rating to a "buy" rating and increased their price target for the stock from $316.00 to $323.00 in a report on Thursday, June 11th. Keefe, Bruyette & Woods upgraded CME Group from a "market perform" rating to an "outperform" rating and set a $305.00 target price on the stock in a research report on Thursday, June 18th. UBS Group cut their target price on CME Group from $310.00 to $260.00 and set a "buy" rating for the company in a research note on Monday, July 6th. JPMorgan Chase & Co. raised their price target on CME Group from $249.00 to $250.00 and gave the company an "underweight" rating in a report on Thursday, July 23rd. Finally, Morgan Stanley upped their price objective on CME Group from $324.00 to $330.00 and gave the stock an "overweight" rating in a report on Thursday, July 23rd. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $288.56.
View Our Latest Stock Report on CME
CME Group Company Profile
(
Free Report)
CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Articles
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
